Difficulty: Medium
Average Score: 65%
Practice
Losartan differs from enalapril in the following respect
Correct answer
A
Rationale
In this scenario, the correct answer is A) It does not potentiate bradykinin. Losartan is an angiotensin II receptor blocker, while enalapril is an angiotensin-converting enzyme (ACE) inhibitor like captopril or lisinopril. ACE inhibitors, such as enalapril, work by inhibiting the conversion of angiotensin I to angiotensin II, resulting in decreased levels of bradykinin breakdown. This can lead to bradykinin accumulation, causing adverse effects like dry cough. Losartan, being an angiotensin II receptor blocker, does not affect bradykinin metabolism, making it less likely to cause cough as a side effect.
Option B) It depresses cardiovascular reflexes is incorrect because neither losartan nor enalapril have significant effects on depressing cardiovascular reflexes. Option C) It impairs carbohydrate tolerance is incorrect as well, as this is not a commonly associated side effect of either drug. Option D) It does not have fetopathic potential is incorrect because both losartan and enalapril are contraindicated in pregnancy due to their potential for causing fetal harm, especially during the second and third trimesters.
Understanding the differences between these two classes of medications is essential for healthcare providers, particularly nurses and pharmacists, when administering or educating patients about antihypertensive drugs. Knowing the unique characteristics of each drug class helps in selecting the most appropriate medication for individual patients based on their medical history and potential side effect profile. This knowledge also plays a crucial role in patient education to ensure medication adherence and optimal therapeutic outcomes.
Option B) It depresses cardiovascular reflexes is incorrect because neither losartan nor enalapril have significant effects on depressing cardiovascular reflexes. Option C) It impairs carbohydrate tolerance is incorrect as well, as this is not a commonly associated side effect of either drug. Option D) It does not have fetopathic potential is incorrect because both losartan and enalapril are contraindicated in pregnancy due to their potential for causing fetal harm, especially during the second and third trimesters.
Understanding the differences between these two classes of medications is essential for healthcare providers, particularly nurses and pharmacists, when administering or educating patients about antihypertensive drugs. Knowing the unique characteristics of each drug class helps in selecting the most appropriate medication for individual patients based on their medical history and potential side effect profile. This knowledge also plays a crucial role in patient education to ensure medication adherence and optimal therapeutic outcomes.